hgh frag 176-191 + ipamorelin Fragment MOD GRF 1-29 + mix 5/5/5 mg hgh frag + ipamorelin HGH

G6PD-d impairs antioxidant processes In individuals with sufficient G6PD activity, GSH neutralizes ROS to maintain redox homeostasis

To maximize safety, use qualified providers and stick to recommended doses

Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile

PMID: 30489688

Dissolve the 20mg lyophilized powder in 0.5ml DMSO, then slowly add this mixture drop-by-drop to 3.5ml of bacteriostatic water in a separate mixing vial (total 4ml solution)